Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Executive Officer, Director
-
Stock Symbol
-
MREO on Nasdaq
Denise Scots-Knight - trading volume in the past year for Mereo BioPharma Group plc
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
American Depositary Shares representing Ordinary Shares |
710K |
$2.41M |
$3.39 |
Jun 26, 2024 |
Direct |
|
|
Share Options (Right to buy) |
850K |
$859K |
$1.01 |
Jan 25, 2024 |
Direct |
American Depository Shares |
|
Performance Based Restricted Stock Unit |
188K |
|
|
Jun 21, 2024 |
Direct |
American Depository Shares |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.